Product Images Trospium Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Trospium Chloride NDC 69097-912 by Cipla Usa Inc.,, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

20mg - 20mg

20mg - 20mg

This text describes the prescription drug Trospium Chloride, which comes in tablet form and is dispensed in a tight container. It should be stored at room temperature and pharmacists should include the package insert or fill out the prescription instructions before dispensing to the patient. The drug should be given separately to each patient, and this information is provided by a subsidiary of Cipla & SIS ann Nl Sross.*

trospium chloride structural formula - image 01

trospium chloride structural formula - image 01

Figure 1 -Mean (+ SD) Concentration-Time Profile for a Single 20 mg Oral Dose of Trospium Chloride Tablets in Healthy Volunteers - image 02

Figure 1 -Mean (+ SD) Concentration-Time Profile for a Single 20 mg Oral Dose of Trospium Chloride Tablets in Healthy Volunteers - image 02

This appears to be a graph displaying the plasma concentration (in nanograms per milliliter) at various times (in hours post-dose) for a particular substance. The x-axis displays the time points and the y-axis displays the concentration values.*

Figure 2 – Mean Change from Baseline in Urinary Frequency/24 Hours, by Visit: Study 1 - image 03

Figure 2 – Mean Change from Baseline in Urinary Frequency/24 Hours, by Visit: Study 1 - image 03

This appears to be a graph or chart showing the mean change with standard error between a placebo group and a group treated with trospium chloride over the course of a certain number of weeks. Additional information or context is not available.*

Figure 3 – Mean Change from Baseline in Urge Incontinence/Week, by Visit: Study 1 - image 04

Figure 3 – Mean Change from Baseline in Urge Incontinence/Week, by Visit: Study 1 - image 04

Figure 4 – Mean Change from Baseline in Urinary Frequency/24 Hours, by Visit: Study 2 - image 05

Figure 4 – Mean Change from Baseline in Urinary Frequency/24 Hours, by Visit: Study 2 - image 05

Figure 5 – Mean Change from Baseline in Urge Incontinence/Week, by Visit: Study 2 - image 06

Figure 5 – Mean Change from Baseline in Urge Incontinence/Week, by Visit: Study 2 - image 06

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.